Steven P. Zielske

1.6k citations
31 papers · 1.2k indexed · h-index 20
Topics
Virus-based gene therapy research (10 papers)CAR-T cell therapy research (7 papers)Epigenetics and DNA Methylation (5 papers)

In The Last Decade

Steven P. Zielske

31 papers receiving 1.2k citations

Peers

Steven P. Zielske
Comparison fields: 5 of 107
  • Molecular Biology 739
  • Oncology 320
  • Genetics 294
  • Cancer Research 153
  • Genetics 136
Replace K Konno with:
K Konno Japan
İlker Dıbırdık United States
Yurai Okaji Japan
Qingyan Liu China
Shuvomoy Banerjee India
Karin Jöhrer Austria
Jinglun Xue China
Divya Singh India
Oliver Alabaster United States
Ranjini K. Sundaram United States
Steven P. Zielske relative to K Konno Japan K Konno's profile →
Citations per field
00.5×11.3×
K Konno · 1×
Citations per year

Countries citing papers authored by Steven P. Zielske

Since Specialization
Citations

This map shows the geographic impact of Steven P. Zielske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven P. Zielske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven P. Zielske more than expected).

Fields of papers citing papers by Steven P. Zielske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven P. Zielske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven P. Zielske. The network helps show where Steven P. Zielske may publish in the future.

Co-authorship network of co-authors of Steven P. Zielske

This figure shows the co-authorship network connecting the top 25 collaborators of Steven P. Zielske. A scholar is included among the top collaborators of Steven P. Zielske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven P. Zielske. Steven P. Zielske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 3
3 1
4 32
5 69
6 100
7 57
8 42
9 13
10 25
11 30
12 21
13 10
14 36
15 67
16 1
17 26
18 50
19 87
20 15

About Steven P. Zielske

Steven P. Zielske is a scholar working on Virology, Oncology and Genetics, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), CAR-T cell therapy research (7 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Virology (91 citations), Biochemistry (89 citations) and Genetics (136 citations). Steven P. Zielske has collaborated with scholars based in United States, South Korea and Israel. Frequent co-authors include Stanton L. Gerson, Maik Hüttemann, Hosam A. Elbaz, Theodore S. Lawrence, Mario Stevenson, Icksoo Lee, Christopher B. Ballas, Moh H. Malek, Jane Reese and Aaron C. Spalding. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026